1 April 2003
Cannabis: good or bad?
The Royal Society of Medicine is opening Cannabis, a meeting of its Open and Clinical Neurosciences Sections to the press at 6pm on 7th April. Highlights include:
Cannabis use now 'more dangerous'
Professor John Henry, St Mary's Hospitals & Imperial
College, London, - The dangers of cannabis
There has been a recent, dangerous shift in the way people
use cannabis and alcohol, Professor Henry will warn. Ordinary
recreational use has given way to a cultural acceptance of regularly
getting stoned to a "far more debilitating degree". Modern cannabis
is nearly ten times the strength the 'flower power' generation
was used to, and in Amsterdam it is at least twice as strong
as in the UK. Professor Henry will outline his concerns about
the lack of data on the risk of smoking cannabis compared with
smoking tobacco, and the emerging mental health problems associated
with THC, cannabis's main active ingredient.
Which diseases can cannabis help?
Dr John Zajicek, Peninsula Medical School, Plymouth, - The
medicinal uses of cannabis
Dr Zajicek is currently involved in the largest double-blind
trial of cannabis-derived medicine ever performed, sponsored
by the MRC, in which patients with multiple sclerosis take capsules
of cannabis-oil or the major component of cannabis, known as
THC, orally. The results of this major study are expected within
the next 3 months. He will explain the rationale for assessing
the potential use of these medicines in multiple sclerosis,
but also mention other conditions which may benefit from this
group of drugs including cancer and aids-related weight loss,
prevention of nausea and vomiting, and also their possible role
in head injury and stroke.
Journalists have 'got it wrong' on cannabis safety
Dr Ian Oliver, Independent Consultant to the UN Drug Control Programme, UK, - The control of cannabis
Dr Oliver's work in the UK and worldwide has made him very concerned
about the way cannabis is portrayed in the media as 'harmless',
particularly with the government's proposal to reclassify the
drug by July 2003. He will talk about what we can learn from
countries such as Holland, where "contrary to what is written
in just about every newspaper in the UK" there is a lack of
control and a severe drug problem which is increasing significantly.
[ends]
